Weight loss guaranteed! But what impact on your diet? A review of GLP-1 and GIP/GLP-1 interventions

FHS
July 30, 2024
3:10 am

Researchers reviewed studies on dietary impacts of GLP-1 and GIP/GLP-1 receptor agonists in obesity and T2D patients, finding significant caloric reduction but limited evaluation of dietary composition.

Alumis aims for this year’s third-largest biotech IPO as it readies for Phase 3

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 25, 2024

U.S. Probes Role of Supply Chain Middlemen in Generic Shortages

WASHINGTON — The Federal Trade Commission (FTC) and HHS jointly issued a request for information on the practices of “opaque middlemen” in the pharmaceutical supply

February 16, 2024

Italian gene therapy startup nabs $52M for rare genetic disease that Moderna is working on

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.